Split that post was a big big strike!! Very insightful

New Post Public Reply Private Reply Replies (2) Message Board
CyberJ Splithappens #63937
927
Split that post was a big big strike!!

Very insightful ramblings!

Quote:
we will be in the black by Aug. this year. My understanding is that there should be profits for the year from that point on.

IMO Kay is being safe here . (Good!) With First Data there will be some light revs, medium and really huge revenues months WHY?

The number of First Data merchants renewing from month to month will vary, however, encryption is now mandatory so the percentage of retention for those renewing should be in very close upper 90s to 100% . IMO when some of the other events below happen , we will be in a positive cash flow well before August IMO, But I am fine with August. We should see confidence building revenues grow month by month at any rate from here.

Since First Data/Fiserv merchant customers are already receiving cutting edge products and great service , and the increase in cost is for the merchants to be compliant, why would they cancel their merchant programs, again very high retention? When fully implemented SFOR will be receiving many millions PER MONTH just from First Data /Fiserv

DSS (yet to start, but when rolled out to 20 mil users the can opt out ), DSS has had S Korean and Chinese keyboards for several months and they are going to roll out to all 20 mil plus end users is imminent, this will be a gap up implementation, First Data (will be a constant roll out of new merchants implementation), SFORs PPS should see a big gap up on this implementation.

Bottom line this year we will see SFOR in the black hugely. The revenues will surge from many revenue streams. Remember the revenues are recurring!

Interesting point you make here splits, new deals not yet disclosed
Quote:
The revenue numbers above do not include new deals not yet disclosed. hmmm
I agree with you on this, there are some accounts who want NDAs , they dont want the bad guys to know what security they are using, we will know they exist, by the revenues.

I would expect PRs from significant revenues also deal-reveal PRs like 350K DSS and First Data (ACS PRs)

Don't sleep on the following
Kay referenced in his interview a Bank deal, digital risk, ?, New patents?? then there is BSAFE deals . There are a few more dots that need to be connected on this deals but each is very big. Each of the aforementioned looks to have a huge impact on revenues this year into making the break out continue into 2021 .

Bottom line SFORs money spigot of revenues is finally opening for SFOR since mid November (First Data), it takes 60+ days for the revenues to start pouring out, November and December might start modestly, (not sure if they wanted to go big during holiday month playing it safe if issue developed on roll out), the spigot will continue to turning clockwise, opening more and more month by month in increasing the merchant count until all merchants have encryption implemented .
Remember each month there will be a constant, relentless increase in cumulative recurring revenues!

If DSS starts in February whether S Korea or China (or both) 20 million end users , SFOR will spike IMO.
Keep rambling on Splits! Great post!


giphy.gif?cid=790b76116895308bc33cd2ad1abd5bf65b01bf21f95552b8&rid=giphy.gif

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 19

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 24

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 30

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 25

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading